Depression in physical illness

Psychiatry

Volumn 5, Issue 3, 2006, Pages 89-92

  Ruttley, Angharad ^a   Reid, Steven ^b  

^a Royal London and St Bartholemew's higher training rotation   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

adjustment disorders; antidepressants; depression; diagnosis; heart disease; hepatitis C; medical illness; Parkinson's disease; prognosis; psychological medicine; stroke

Indexed keywords

ALPHA INTERFERON; AMANTADINE; ANABOLIC AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; ANTIVIRUS AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CIMETIDINE; CLONIDINE; CORTICOSTEROID; DIGOXIN; EFAVIRENZ; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERFERON; LEVODOPA; NEVIRAPINE; NIFEDIPINE; ORAL CONTRACEPTIVE AGENT; PROCAINAMIDE; PROPRANOLOL; RESERPINE; RIBAVIRIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VIGABATRIN; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANXIETY; ARTHRITIS; ARTICLE; ASTHMA; BACKACHE; BRADYKINESIA; CANCER; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CROHN DISEASE; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; ELECTROCONVULSIVE THERAPY; EMPHYSEMA; ENDOCRINE DISEASE; EPILEPSY; FATIGUE; GUILT; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEPATITIS B; HEPATITIS C; HUMAN; HUNTINGTON CHOREA; INFECTIOUS MONONUCLEOSIS; INSOMNIA; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MIGRAINE; MOOD; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; QUESTIONNAIRE; RHEUMATIC DISEASE; STATISTICAL SIGNIFICANCE; STROKE; SUICIDE; SYMPTOM;

EID: 33845361940     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1383/psyt.2006.5.3.89     Document Type: Article

References (13)

1. Endicott J. Measurement of depression in patients with cancer. Cancer 53 suppl (1984) 2243-2248
2. Patten S., Beck C., Kassam A., Williams J., Barbui C., and Metz L. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry 50 (2005) 195-202
3. Gilbody S., House A., and Sheldon T. Routinely administered questionnaires for depression and anxiety: systematic review. BMJ 322 (2001) 406-409
4. Chochinov H., Wilson K., Enns M., and Lander S. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry 154 (1997) 674-676
5. Robinson R. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biological Psychiatry 54 (2003) 376-387
6. Carson A., MacHale S., Allen K., et al. Depression after stroke and lesion location: a systematic review. Lancet 356 (2001) 122-126
7. Glassman A., O'Connor C., Califf R., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002) 701-709
8. Pariante C., Landau S., and Carpiniello B. Interferon alfa-induced adverse effects in patients with a psychiatric disagnosis. New Engl J Med 347 (2002) 148-149
9. Gill D., and Hatcher S. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. J Psychosom Res 47 (1999) 131-143
10. Cole M., and Bellavance F. Depression in elderly medical inpatients: a meta-analysis of outcomes. Can Med Assoc J 157 (1998) 1055-1060
11. Hackett M., Anderson C., and House A. Interventions for treating depression after stroke. The Cochrane Database of Systematic Reviews Issue 2 (2004)
12. In: Robertson M., and Katona C. (Eds). Depression and physical illness (1997), John Wiley and Sons, London
13. Taylor D., Paton C., and Kerwin R. The Maudsley prescribing guidelines (2005), Taylor & Francis, Oxford